NR3C1 and breast cancer: A retrospective meta-analysis in primary breast tumors showed that high gene expression of GR (NR3C1) in the bulk tumor was associated with significantly worse relapse-free survival (RFS) among ER-negative early stage breast cancer, but better survival in ER-positive breast cancer.